Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Acro Biomedical (ACBM) Operating Expenses (2016 - 2025)

Acro Biomedical (ACBM) has 10 years of Operating Expenses data on record, last reported at $16377.0 in Q4 2025.

  • For Q4 2025, Operating Expenses rose 72.97% year-over-year to $16377.0; the TTM value through Dec 2025 reached $154024.0, up 305.77%, while the annual FY2025 figure was $154024.0, 305.77% up from the prior year.
  • Operating Expenses reached $16377.0 in Q4 2025 per ACBM's latest filing, down from $115099.0 in the prior quarter.
  • Across five years, Operating Expenses topped out at $4.0 million in Q3 2022 and bottomed at $8934.0 in Q1 2025.
  • Average Operating Expenses over 5 years is $1.6 million, with a median of $494209.5 recorded in 2021.
  • Peak YoY movement for Operating Expenses: surged 5050.84% in 2021, then plummeted 99.74% in 2024.
  • A 5-year view of Operating Expenses shows it stood at $4.0 million in 2021, then dropped by 0.12% to $4.0 million in 2022, then plummeted by 99.56% to $17401.0 in 2023, then crashed by 45.59% to $9468.0 in 2024, then skyrocketed by 72.97% to $16377.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Operating Expenses were $16377.0 in Q4 2025, $115099.0 in Q3 2025, and $13614.0 in Q2 2025.